Ibr/Brsv/P13/Bvd T1, T2(Us) Lv
96 adverse event reports submitted to the FDA
Active Ingredients
Administration Routes
Species Affected
Most Affected Breeds
Most Reported Reactions
Outcome Breakdown
Data Summary
| Metric | Value |
|---|---|
| Total adverse event reports | 96 |
| Reports involving death | 85 |
| Case-fatality rate (reported events) | 8850.0% |
| Distinct species in reports | 1 |
| Distinct breeds in reports | 12 |
| Distinct reactions reported | 20 |
| Active ingredients on file | 1 |
Source: FDA Center for Veterinary Medicine — Adverse Event Reporting (CVM AER). Counts reflect voluntary reports only.
Ibr/Brsv/P13/Bvd T1, T2(Us) Lv Adverse Event Insights
The FDA Center for Veterinary Medicine database currently holds 96 adverse event reports referencing Ibr/Brsv/P13/Bvd T1, T2(Us) Lv, including 85 reports in which the animal died — a 8850.0% case-fatality figure among reported events only, not a population-level mortality rate. Active ingredient on file: Ibr/Brsv/P13/Bvd T1, T2(Us) Lv. Reported administration routes include Subcutaneous, Unknown, Oral. These numbers reflect voluntary submissions from pet owners, veterinarians, and manufacturers and therefore under-represent mild events and over-represent severe ones — a pattern the FDA has documented repeatedly for pharmacovigilance datasets.
The species most frequently named in Ibr/Brsv/P13/Bvd T1, T2(Us) Lv reports are Cattle (96 reports), with Cattle accounting for the largest share. Within those species, Cattle (other) (44), Crossbred Bovine/Cattle (14), Aberdeen Angus (14) appear most often — though breed popularity and ownership density shape these counts as much as any drug-specific sensitivity. This distribution matters because the same active ingredient can behave very differently across body sizes, ages, and species physiology.
The most commonly reported clinical signs associated with Ibr/Brsv/P13/Bvd T1, T2(Us) Lv are Death (79), Lack of efficacy - NOS (53), Lack of efficacy (bacteria) - NOS (16), Respiratory signs (6). Of the 200 reports with a coded outcome, Died is the leading category at 41.0%. Because FDA adverse event data describes correlation rather than causation, these figures are best used to frame informed questions with a veterinarian and to compare reporting patterns across related products — not as a standalone safety verdict on Ibr/Brsv/P13/Bvd T1, T2(Us) Lv.
Source: FDA Center for Veterinary Medicine — Adverse Event Reports FDA Center for Veterinary Medicine — Adverse Event Reports Data reflects voluntary submissions and may not represent actual incidence rates
Read our methodology — how this data is sourced, computed, and verified.